Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmunoWay is a biotechnology company specializing in the development and manufacture of high-quality research reagents for the global life sciences community. The company offers an extensive catalog of products, including phospho-specific antibodies, total antibodies, ELISA kits, and recombinant proteins. These tools are primarily used in cell signaling research and the study of various disease mechanisms. Headquartered in Plano, Texas, ImmunoWay serves academic institutions, pharmaceutical companies, and diagnostic laboratories worldwide. Their products support research across diverse therapeutic areas such as oncology, immunology, and neuroscience. The company focuses on providing validated and reliable tools to accelerate scientific discovery and drug development processes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmunoWay.